A Phase II Study of Endostar (Recombinant Human Endostatin) With Cisplatin and Capecitabine (Xeloda) as 1st Line Treatment in the Advanced Gastric Cancer.
Phase of Trial: Phase II
Latest Information Update: 20 May 2015
At a glance
- Drugs Endostatin (Primary) ; Capecitabine; Cisplatin
- Indications Gastric cancer
- Focus Therapeutic Use
- Acronyms ENDOCX
- 18 May 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 17 Feb 2009 New trial record